| NCT05673811 | Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic Cancer | COMPLETED | PHASE2 | 2023-01-10 | 2025-03-28 | 2025-03-28 |
| NCT05045833 | Multiple Ascending Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Orally Administered SYN 020 | COMPLETED | PHASE1 | 2021-10-18 | 2022-03-21 | 2022-02-22 |
| NCT04815993 | Pharmacokinetics, Safety, and Tolerability of SYN-020 | COMPLETED | PHASE1 | 2021-03-22 | 2021-09-30 | 2021-05-18 |
| NCT04692181 | SYN-004 Safety and Tolerability in Allo-HCT Subjects | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2021-02-15 | 2026-12 | 2025-12 |
| NCT02563106 | A Study of SYN-004 for the Prevention of C.Diff in Patients With a LRTI | COMPLETED | PHASE2 | 2015-10 | 2016-11 | 2016-11 |
| NCT02493036 | A Single-Dose, Open-Label, Study to Evaluate the Sustainability of the Effects of SYN-010 in Patients With IBS-C | COMPLETED | PHASE2 | 2015-10 | 2015-12 | 2015-12 |
| NCT02473640 | A Study Evaluating the Effect of Esomeprazole on SYN-004 Degradation of Ceftriaxone In Adults With an Ileostomy | COMPLETED | PHASE1, PHASE2 | 2015-06 | 2016-04 | 2016-04 |
| NCT02495623 | A Study of the Effect of SYN-010 on Subjects With IBS-C | COMPLETED | PHASE2 | 2015-06 | 2015-11 | 2015-10 |
| NCT02419001 | A Study to Evaluate the Effect of SYN-004 on the PK of IV Ceftriaxone in Adults With a Functioning Ileostomy | COMPLETED | PHASE1, PHASE2 | 2015-03 | 2015-10 | 2015-09 |
| NCT02045602 | Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine and Abraxane® in Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2014-01 | 2020-01 | 2019-05 |
| NCT02045589 | A Phase I Dose Escalation Study of Intratumoral VCN-01 Injections With Gemcitabine and Abraxane® in Patients With Advanced Pancreatic Cancer | COMPLETED | PHASE1 | 2014-01 | 2018-09 | 2016-10 |